CRISPR Therapeutics AG — Director's Dealing 2016

Oct 24, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CRISPR Therapeutics AG (CRSP)
CIK: 0001674416
Period of Report: 2016-10-24

Reporting Person: Hadley Harbor Master Investors (Cayman) L.P. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-10-24	Common Shares	C	744380	—	Acquired	744380	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-10-24	Series B Convertible Preferred Shares	$	C	744380	Disposed		Common Shares (744380)	Direct

Footnotes

F1: The Series B Convertible Preferred Shares converted into common shares on a one-for-one basis and had no expiration date.